Overall, although the human CRC mutational data suggest SOX9 inactivation may interact with APC mutation–dependent tumorigenesis, the apparent relationship between SOX9 loss and APC mutation status in CRCs does not appear to reflect a functional connection between SOX9 expression status and β-catenin/TCF–dependent transcriptional activity. This evidence concerns the gene APC and colorectal carcinoma.